U.S. flag

An official website of the United States government

Filters

See more specimen types...

Results: 1 to 20 of 44

Tests names and labsConditionsGenes, analytes, and microbesMethods

JAK2 Targeted Mutation Analysis (V617F)

Genetics Center
United States
31
  • T Targeted variant analysis

HLA Loss of Heterozygosity Evaluation

Versiti Diagnostic Laboratories Versiti, Inc
United States
41
  • H Detection of homozygosity
  • U Uniparental disomy study (UPD)

Calreticulin Exon 9 Mutation, JAK2 V617F Quant and Exons 12-15 and MPL Mutation Analysis

PathGroup
United States
93
  • T Targeted variant analysis

JAK2 V617F Mutation Detect and Quant and JAK2 Exons12-15 Mutation Analysis

PathGroup
United States
51
  • T Targeted variant analysis

Calreticulin Exon 9 Mutation, MPL Mutation analysis and JAK2 Exons12-15 Mutation Analysis

PathGroup
United States
93
  • T Targeted variant analysis

Calreticulin Exon 9 Mutation and JAK2 V617F Quant and Exons 12-15

PathGroup
United States
82
  • T Targeted variant analysis

Calreticulin Exon 9 Mutation, MPL and JAK2 V617F Quant

PathGroup
United States
93
  • T Targeted variant analysis

Calreticulin Exon 9 Mutation and JAK2 V617F Quant

PathGroup
United States
82
  • T Targeted variant analysis

HemeComplete NextGen Sequencing Assay with Calreticulin Exon 9 Mutation, FLT3 ITD and TKD Analysis and T-Cell Clonality Analysis

PathGroup
United States
23160
  • T Targeted variant analysis

HemeComplete NextGen Sequencing Assay with Calreticulin Exon 9 Mutation, FLT3 ITD and TKD Analysis and JAK2 V617F Quant

PathGroup
United States
18160
  • T Targeted variant analysis

BCR/ABL IS Quant CML and JAK2 V617F Quant and JAK2 Exon 12-15

PathGroup
United States
73
  • T Targeted variant analysis

BCR/ABL IS Quant CML and JAK2 V617F Quant

PathGroup
United States
73
  • T Targeted variant analysis

BCR CML IS_expanded JAK2 +V617F quant_CALR_MPL

PathGroup
United States
115
  • T Targeted variant analysis

BCR CML IS_JAK2_CALR_MPL

PathGroup
United States
115
  • T Targeted variant analysis

BCR/ABL CML IS, CALR and JAK2 exon 12-15 (V617F Quant)

PathGroup
United States
104
  • T Targeted variant analysis

BCR/ABL IS Quant CML+CALR+Expanded JAK2

PathGroup
United States
104
  • T Targeted variant analysis

BCR/ABL, CALR, JAK2, MPL

PathGroup
United States
115
  • T Targeted variant analysis

BCR/ABL Quant Non-CML and JAK2 V617F Mutation Detect and Quant

PathGroup
United States
73
  • T Targeted variant analysis

BCR/ABL, CALR, expanded JAK2, MPL

PathGroup
United States
115
  • T Targeted variant analysis

BCR/ABL Quant Non-CML, CALR and JAK2 exon 12-15 (V617F Quant)

PathGroup
United States
104
  • T Targeted variant analysis

Results: 1 to 20 of 44

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.